Literature DB >> 16753591

The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas.

Julie M Wu1, Michael J Borowitz, Edward G Weir.   

Abstract

We studied 34 low- and 30 high-grade CD10+ B-cell lymphomas. Forward light scatter (FSC) and CD71 fluorescence intensity (CD71i) of tumor cells were measured and normalized by corresponding values for resting T cells. Significant differences in CD71i values between low- and high-grade lymphomas were observed by the Mann-Whitney U test (P < .001) and receiver operating characteristic (ROC) curve analysis (P < .001). FSC was not significantly different between low- and high-grade lymphomas; the area under the ROC curve was less than that for CD71i. Neither FSC nor CD71i significantly differentiated follicular lymphoma (FL) grades. A comparison of all FLs (grades 1-3) and non-FL high-grade lymphomas (Burkitt lymphoma [BL] and large B-cell lymphoma [LBCL]) showed significant differences in CD71i (P < .001) and FSC (P = .021). Differences were significant in CD71i and FSC between FL and LBCL (P < .001) but not between FL and BL. CD71i is more potent than FSC for distinguishing CD10+ low- from high-grade lymphomas and FL from non-FL high-grade lymphomas. Sensitivity and specificity are limited owing to inability to identify FL3. In ROC analysis, a high value for CD71i can identify BL and LBCL with a high degree of certainty.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16753591     DOI: 10.1309/X8LB-RRBB-C43P-L9HC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system.

Authors:  Paul McGowan; Nicole Nelles; Jana Wimmer; Dawn Williams; Jianguo Wen; Marilyn Li; April Ewton; Choladda Curry; Youli Zu; Andrea Sheehan; Chung-Che Jeff Chang
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

2.  A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Authors:  Grzegorz Rymkiewicz; Beata Grygalewicz; Magdalena Chechlinska; Katarzyna Blachnio; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Renata Woroniecka; Michalina Zajdel; Katarzyna Domanska-Czyz; David Martin-Garcia; Ferran Nadeu; Pawel Swoboda; Jolanta Rygier; Barbara Pienkowska-Grela; Jan Konrad Siwicki; Monika Prochorec-Sobieszek; Itziar Salaverria; Reiner Siebert; Jan Walewski
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

3.  High yield secretion of human erythropoietin from tobacco cells for ex vivo differentiation of hematopoietic stem cells towards red blood cells.

Authors:  Uddhab Karki; Tristen Wright; Jianfeng Xu
Journal:  J Biotechnol       Date:  2022-06-28       Impact factor: 3.595

4.  Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow.

Authors:  Huy Q Dinh; Tobias Eggert; Melissa A Meyer; Yanfang Peipei Zhu; Claire E Olingy; Ryan Llewellyn; Runpei Wu; Catherine C Hedrick
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

5.  Plant cell-secreted stem cell factor stimulates expansion and differentiation of hematopoietic stem cells.

Authors:  Xiaoting Wang; Uddhab Karki; Hasara Abeygunaratne; Carmela UnnoldCofre; Jianfeng Xu
Journal:  Process Biochem       Date:  2020-09-25       Impact factor: 3.757

6.  Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis.

Authors:  Majd Al Shaarani; Rodney E Shackelford; Samip R Master; Glenn M Mills; Yasir AlZubaidi; Ahmed Mamilly; Eric X Wei
Journal:  Case Rep Hematol       Date:  2019-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.